2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide

C26H31NO7 — CID 177117958

IUPAC2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
SMILESCOc1cc2c(c(OC)c1OC)-c1cc(C)c(=O)c(O[C@H]3CCOC3)cc1[C@H](CC(N)=O)CC2
InChIInChI=1S/C26H31NO7/c1-14-9-19-18(12-20(24(14)29)34-17-7-8-33-13-17)15(11-22(27)28)5-6-16-10-21(30-2)25(31-3)26(32-4)23(16)19/h9-10,12,15,17H,5-8,11,13H2,1-4H3,(H2,27,28)/t15-,17-/m0/s1
InChIKeyQMXJSUUGVOCQQW-RDJZCZTQSA-N
MW469.53 g/mol
LogP3.12
Rot. Bonds7

About 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide

2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide (PubChem CID 177117958) has the molecular formula C26H31NO7 and a molecular weight of 469.53 g/mol. Its IUPAC name is 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide.

Molecular Properties

Compound Name2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
PubChem CID177117958
Molecular FormulaC26H31NO7
Molecular Weight469.53 g/mol
Exact Mass469.21
IUPAC Name2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
SMILESCOc1cc2c(c(OC)c1OC)-c1cc(C)c(=O)c(O[C@H]3CCOC3)cc1[C@H](CC(N)=O)CC2
InChIInChI=1S/C26H31NO7/c1-14-9-19-18(12-20(24(14)29)34-17-7-8-33-13-17)15(11-22(27)28)5-6-16-10-21(30-2)25(31-3)26(32-4)23(16)19/h9-10,12,15,17H,5-8,11,13H2,1-4H3,(H2,27,28)/t15-,17-/m0/s1
InChIKeyQMXJSUUGVOCQQW-RDJZCZTQSA-N
XLogP3.12
TPSA106.31 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500469.53
LogP ≤ 53.12
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide?
The IUPAC name of 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide (CID 177117958) is 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide.
What is the SMILES notation for 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide?
The canonical SMILES for 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide is COc1cc2c(c(OC)c1OC)-c1cc(C)c(=O)c(O[C@H]3CCOC3)cc1[C@H](CC(N)=O)CC2.
What is the InChIKey of 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide?
The InChIKey is QMXJSUUGVOCQQW-RDJZCZTQSA-N. The full InChI is InChI=1S/C26H31NO7/c1-14-9-19-18(12-20(24(14)29)34-17-7-8-33-13-17)15(11-22(27)28)5-6-16-10-21(30-2)25(31-3)26(32-4)23(16)19/h9-10,12,15,17H,5-8,11,13H2,1-4H3,(H2,27,28)/t15-,17-/m0/s1.
What are the key properties of 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide?
2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide has a molecular weight of 469.53 g/mol, XLogP of 3.12, 7 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(7S)-1,2,3-trimethoxy-11-methyl-10-oxo-9-[(3S)-oxolan-3-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide is sourced from PubChem (CID 177117958), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).